Efficacy and Safety of Zenoctil in Reducing Body Weight

Inclusion Criteria: * Caucasian males and females, age 18 to 60 years * 25 kg/m2 ≤ BMI ≤32 kg/m2 * Expressed desire for weight loss * Accustomed to 3 main meals a day * Consistent and stable body weight 3 months prior to study enrollment * Commitment to avoid the use of other weight loss products/programs during the study * Commitment to adhere to diet recommendation * Females' agreement to use appropriate birth control methods during the active study period * Subject declares in writing his/her consent to participate, understands requirements of the study and is willing to comply Exclusion Criteria: * Known sensitivity to Garcinia cambogia, Lagerstroemia speciosa (other members of Lythraceae family), caffeine, tannins * History of diabetes mellitus or other endocrine disorders * Fasting blood glucose \>7 mmol/L * Treatment with systemic corticosteroids within the last 12 months * Current use of antidepressants * Uncontrolled hypertension (\>160/110) or other uncontrolled cardiac, pulmonary, renal, or liver disease, determined to be clinically significant by the investigator * Presence of acute or history of chronic gastrointestinal disease * Schizophrenia or other diagnosed psychiatric disorders * Any other acute or chronic disease or any other medical condition which, in the investigator's view, may preclude subject's inclusion (e.g., cancer, HIV) * Bariatric surgery * Abdominal surgery within the last 6 months * History of eating disorders like bulimia, anorexia nervosa * Changes in the dose of estrogen, contraceptives or thyroid hormone within the last 3 months * Pregnancy or nursing * Any medication or use of products for the treatment of obesity (e.g., fat binder, carbohydrate blocker/starch blocker, fat burner, satiety products etc.) within the last 6 weeks * More than 3 hours strenuous sport activity per week * History of abuse of drugs, alcohol or medication * Smoking cessation within the 6 months prior to this study * Incompliance due to language difficulties * Participation in another study during the last 4 weeks * Clinically relevant excursions of safety parameters